Algorithm for personalized therapy of patients with alcoholism with comorbid disorders of the detoxifying function of the liver and cognitive disorders

Algorithm for personalized therapy of patients with alcoholism with comorbid disorders of the detoxifying function of the liver and cognitive disorders

 

Authors

 

N.I. Kisel

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

R.I. Bedarev

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

A.I. Mandel

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

T.V. Shushpanova

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

L.V. Mazurova

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

T.P. Novozheeva

Учреждение город страна

A.V. Solonsky

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

N.P. Garganeeva

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation; Federal State Budgetary Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation, Tomsk, Russian Federation

T.G. Burdovitsina

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

I.A. Gonchikova

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

T.A. Popova

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

 

https://doi.org/10.26617/1810-3111-2022-4(117)-33-43

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2022; 4 (117):  33-43.

 

Abstract

Background. Disfunctions of the metabolic processes of the liver as a result of exposure to alcohol intoxication reduce cognitive functioning and induce cognitive disorders. The severity of complications of alcoholism is associated with the severity of metabolic disorders. In patients with alcoholism with comorbid liver damage, signs of cognitive impairment are observed already in the early stages of the disease and are accompanied by disorders of attention, memory, perception, which in the future often lead to social maladaptation and disability. Objective. Identification of the relationship between indicators of disturbance of the detoxifying function of the liver and cognitive disorders in patients with alcohol dependence in order to develop an algorithm for personalized therapy. Materials and Methods. Based on the Addictive State Department of Mental Health Research Institute, the study sample (n=40) was formed of males, whose mean age was 42.4±11.9 years, with mental and behavioral disorders diagnosed according to ICD-10, associated with alcohol use (F10), impaired detoxifying liver function and cognitive impairment. To assess the dynamics of the mental state in patients with alcohol dependence, psychological testing was carried out twice (at admission and after complex therapy) using the Hamilton anxiety scale. Cognitive impairment was screened using the Montreal Cognitive Scale (MoCA), short-term and long-term memory was assessed using psychodiagnostic tests (Pictograms, Learning 10 words). The obsessive-compulsive scale (OCS) of craving for alcohol was used for self-assessment of ideational manifestations of attitudes towards alcohol. The dynamics of blood biochemical parameters (ALT, AST, total bilirubin, direct and indirect bilirubin, cholesterol, alkaline phosphatase) were studied in dynamics. Results. Against the background of ongoing drug therapy, there was a regression of obsessive-compulsive craving for alcohol, which was confirmed by a decrease in the mean score for OCS from 36.5±4.2 to 3.47±2.03 points. Blood biochemical parameters (ALT, AST, total bilirubin, cholesterol) normalized. Cognitive abilities improved, which was justified by an increase in the total number of MoCA scores (22.7±4.3 points at the time of admission, 26.5±1.6 points after therapy). Findings. In patients with severe alcohol dependence on the background of liver damage, as evidenced by a 3-fold or more increase in serum ALT and mood disorders AST compared with the norm, low indicators of short-term and long-term memory, severe impairment of visual-constructive praxis and abilities, concentration of attention, which was confirmed by the total (15.9±1.3 points) values according to the Montreal Cognitive Assessment Scale. Restoration or compensation of the detoxifying function of the liver and improvement of cognitive potential due to the use of drugs combining hepatoprotective and neuroprotective effects in a combined therapy regimen becomes a favorable factor for subsequent stages of patient rehabilitation and prevention of relapses of alcohol dependence.

 

Keywords: alcohol dependence, cognitive disorders, metabolic processes, detoxifying function of the liver, personalized therapy.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Kisel N.I., Bedarev R.I., Mandel A.I., Shushpanova T.V., Mazurova L.V., Novozheeva T.P., Solonsky A.V., Garganeeva N.P., Burdovitsina T.G., Gonchikova I.A., Popova T.A. Algorithm for personalized therapy of patients with alcoholism with comorbid disorders of the detoxifying function of the liver and cognitive disorders.Siberian Herald of Psychiatry and Addiction Psychiatry.2022; 4 (117): 33-43. https://doi.org/10.26617/1810-3111-2022-4(117)-33-43

 

REFERENCES

  1. Socially significant diseases of the population of Russia in 2021. Statistical materials. Moscow, 2021:73 (in Russian).
  2. Kilian C, Rehm J, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O'Donnell A, Petruželka B, Rogalewicz V, Schulte B, Manthey J; European Study Group on Alcohol Use and COVID-19. Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. Addiction. 2021 Dec;116(12):3369-3380. doi: 10.1111/add.15530. Epub 2021 Jun 9. PMID: 34109685.
  3. Semke VYa, Kupriyanova IE, Shushpanova TV. Mental health of the population of Siberia and the Far East. S.S. Korsakov Journal of Neurology and Psychiatry. 2007;107(3):78 (in Russian).
  4. BokhanNA, MandelAI, ArtemyevIA, NevidimovaTI, BatukhtinaEI, VoevodinIV, AboloninAF, SolonskyAV, ProkopievaVD, ToshchakovaVA, EpimakhovaEV, ShushpanovaTV. Clinical and pathobiological patterns of formation and pathomorphosis of alcoholism in socially organized populations. Siberian Herald of Psychiatry and Addiction Psychiatry.2015;3(88):53-63(in Russian).
  5. Beaglehole R, Bonita R. Alcohol: a global health priority. Lancet. 2009 Jun 27;373(9682):2173-4. doi: 10.1016/S0140-6736(09)61168-5. PMID: 19560583.
  6. BokhanNA, MandelAI, ArtemyevIA, VetluginaTP, IvanovaSA, SolonskyAV, NevidimovaTI, NovozheevaTP, ShushpanovaTV, StoyanovaIYa. Neurobiological and psychosocial regularities in the formation of the clinical heterogeneity of addictive disorders (regional, preventive aspects). Siberian Herald of Psychiatry and Addiction Psychiatry.2009;5(56):20-26(in Russian).
  7. Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol. 2013 Mar;18(2):203-13. doi: 10.1111/j.1369-1600.2011.00418.x. Epub 2012 Jan 20. PMID: 22264351.
  8. Peshkovskaya AG, Mandel AI, Ivanova SA, Prokopieva VD. Influence of alcoholism on cognitive functions among representatives of the indigenous population of Siberia.Siberian Herald of Psychiatry and Addiction Psychiatry. 2016;4(93):105-110 (in Russian).
  9. BokhanNA, MandelAI, IvanovaSA, ProkopievaVD, ArtemyevIA, NevidimovaTI, MasterovaEI, VoevodinIV, AboloninAF, ShushpanovaTV. Old and new problems in narcology in the context of interdisciplinary research. Journal of Addiction Issues. 2017;1:26-62 (in Russian).
  10. KvartychEI, TikhonovaIN, PomazanovaEV. Metabolism of ethanol in the liver and predisposition to alcohol. Sociology. Philosophy. Applied Research. 2020;6:21-24(in Russian).
  11. Sutko IP, Semenenya IN, Shlyakhtun AG. The role of isoforms of cytochrome P450 of the endoplasmic reticulum of hepatocytes in the metabolism of ethanol. Hepatology and Gastroenterology. 2021;5(2):132-137(in Russian).
  12. Maev IV, Abdurakhmanov DT, Andreev DN. Alcoholic liver disease: state-of-the-art. Therapeutic Archive. 2014;86(4):108-116(in Russian).
  13. Zhmurov DV, Parfenteva MA, Semenova YuV, Rubtsov DA. Cirrhosis of the liver. Colloquium-journal. 2020;11(63):57-62. doi:10.24411/2520-6990-2020-11732 (in Russian).
  14. KiselevaYaV, ZharikovYuO, RVMaslennikovRV, PavlovChS, NikolenkoVN. Molecular aspects of the progression of liver fibrosis of alcoholic etiology. Medical Bulletin of the North Caucasus. 2020;15(2):288-293(in Russian).
  15. Sutherland GT, Sheedy D, Kril JJ. Neuropathology of alcoholism. Handb Clin Neurol. 2014;125:603-15. doi: 10.1016/B978-0-444-62619-6.00035-5. PMID: 25307599.
  16. Shevchenko OI, Lakhman OL, Katamanova EV. Comparative characteristic of cognitive impairment in alcoholic and discirculatory encephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2020; 120(5): 16-23. https://doi.org/10.17116/jnevro202012005116(in Russian).
  17. OchilovUU, TuraevBT, KhushvaktovaDKh. The prevalence of cognitive impairment in patients with alcoholism. Bulletin of Science and Education. 2020;17-2(95):104-106(in Russian).
  18. NovozheevaTP, ShushpanovaTV, UdutVV, BokhanNA. Creation of pharmacological agents for activating detoxification systems: experience and prospects. Experimental and Clinical Pharmacology. 2017. V. 80, No. 56. S. 23-24(in Russian).
  19. ShushpanovaTV, BokhanNA, StankevichKS, NovozheevaTP, MandelAI, SchastnyyED, KiselNI, ShushpanovaOV, UdutVV, BoevRS, KnyazevaEM. An innovative modulator of GABA receptors ‒ an activator of the microsomal cytochrome P450 oxidase system in patients with alcoholism. Chemical Pharmaceutical Journal. 2020. V. 54, No. 11. S. 9-16(in Russian).